Table 1.
Participant characteristics
n (%) | Mean ± SD (range) | |
---|---|---|
Demographics | ||
Age (years) | 49.0 ± 11.7 (25–79) | |
Gender (M:F) | 23:22 | |
Duration of diagnosis (years) | 15.6 ± 11.2 (1–45) | |
BMI (kg/m2) | 27.4 ± 5.6 (17.3–41.6) | |
Work status | ||
Paid employment | 31 (69%) | |
Retired/medically retired | 9 (20%) | |
Unemployed | 3 (7%) | |
Off work | 1 (2%) | |
Student | 1 (2%) | |
Current treatment | ||
Anti-TNF | 25 (50%) | |
NSAIDs | 30 (60%) | |
Pain relief | 22 (44%) | |
Physio/exercise class | 4 (8%) | |
Disease activity/mobility/function | ||
BASDAI (0–10) | 4.5 ± 2.3 (0.4–8.7) | |
Low disease activity (BASDAI < 4) | 17 (38%) | |
Active disease activity (BASDAI ≥ 4) | 28 (62%) | |
BASMI (0–10) | 3.6 ± 1.8 (0.4–7.5) | |
BASFI (0–10) | 4.4 ± 2.6 (0.4–9.3) | |
Exercise capacity | ||
6 min walk test (m) | 414 ± 106 (121–622) |
n number, SD standard deviation, m metres, M male, F female, BMI Body Mass Index, TNF Tumour Necrosis Factor, NSAIDs Non-Steroidal Anti-Inflammatory Drugs, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASMI Bath Ankylosing Spondylitis Metrology Index, BASFI Bath Ankylosing Spondylitis Functional Index